JPS5747667B2 - - Google Patents

Info

Publication number
JPS5747667B2
JPS5747667B2 JP48057638A JP5763873A JPS5747667B2 JP S5747667 B2 JPS5747667 B2 JP S5747667B2 JP 48057638 A JP48057638 A JP 48057638A JP 5763873 A JP5763873 A JP 5763873A JP S5747667 B2 JPS5747667 B2 JP S5747667B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP48057638A
Other languages
Japanese (ja)
Other versions
JPS4948666A (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4948666A publication Critical patent/JPS4948666A/ja
Publication of JPS5747667B2 publication Critical patent/JPS5747667B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP48057638A 1972-05-24 1973-05-23 Expired JPS5747667B2 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7206941,A NL175988C (nl) 1972-05-24 1972-05-24 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.

Publications (2)

Publication Number Publication Date
JPS4948666A JPS4948666A (cg-RX-API-DMAC7.html) 1974-05-11
JPS5747667B2 true JPS5747667B2 (cg-RX-API-DMAC7.html) 1982-10-12

Family

ID=19816103

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48057638A Expired JPS5747667B2 (cg-RX-API-DMAC7.html) 1972-05-24 1973-05-23

Country Status (13)

Country Link
US (1) US3850904A (cg-RX-API-DMAC7.html)
JP (1) JPS5747667B2 (cg-RX-API-DMAC7.html)
AU (1) AU470908B2 (cg-RX-API-DMAC7.html)
BE (1) BE799939A (cg-RX-API-DMAC7.html)
CA (1) CA1030954A (cg-RX-API-DMAC7.html)
CH (1) CH587229A5 (cg-RX-API-DMAC7.html)
DE (1) DE2326033C2 (cg-RX-API-DMAC7.html)
FR (1) FR2185412B1 (cg-RX-API-DMAC7.html)
GB (1) GB1435384A (cg-RX-API-DMAC7.html)
HU (1) HU169159B (cg-RX-API-DMAC7.html)
NL (1) NL175988C (cg-RX-API-DMAC7.html)
SE (1) SE407215B (cg-RX-API-DMAC7.html)
ZA (1) ZA733211B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438029A (en) 1978-01-19 1984-03-20 Research Corporation Synthetic peptides
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
NL8101724A (nl) * 1981-04-08 1982-11-01 Akzo Nv Peptiden met zenuw-regenererende eigenschappen.
US4500713A (en) * 1982-09-23 1985-02-19 Usv Pharmaceutical Corporation Therapeutic dipeptides
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
CN117715632A (zh) 2021-03-09 2024-03-15 恩赛斯生物科学股份有限公司 包含酶可裂解的前药和萘莫司他的组合物及其使用方法
KR20230174213A (ko) 2021-03-09 2023-12-27 엔사이스 바이오사이언시즈 인크. 나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1302396A (fr) * 1961-03-10 1962-08-31 Ciba Geigy Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine
NL6509727A (cg-RX-API-DMAC7.html) * 1965-07-28 1967-01-30
GB1301738A (cg-RX-API-DMAC7.html) * 1969-07-09 1973-01-04

Also Published As

Publication number Publication date
NL175988B (nl) 1984-09-03
DE2326033A1 (de) 1973-12-20
BE799939A (fr) 1973-11-23
SE407215B (sv) 1979-03-19
NL175988C (nl) 1985-02-01
JPS4948666A (cg-RX-API-DMAC7.html) 1974-05-11
AU470908B2 (en) 1976-04-01
US3850904A (en) 1974-11-26
GB1435384A (en) 1976-05-12
HU169159B (cg-RX-API-DMAC7.html) 1976-10-28
FR2185412A1 (cg-RX-API-DMAC7.html) 1974-01-04
DE2326033C2 (de) 1983-10-27
CA1030954A (en) 1978-05-09
FR2185412B1 (cg-RX-API-DMAC7.html) 1976-12-03
NL7206941A (cg-RX-API-DMAC7.html) 1973-11-27
CH587229A5 (cg-RX-API-DMAC7.html) 1977-04-29
ZA733211B (en) 1974-04-24
AU5575073A (en) 1974-11-21

Similar Documents

Publication Publication Date Title
FR2212601B1 (cg-RX-API-DMAC7.html)
CS178160B2 (cg-RX-API-DMAC7.html)
FR2185412B1 (cg-RX-API-DMAC7.html)
FR2183289B1 (cg-RX-API-DMAC7.html)
JPS4919077A (cg-RX-API-DMAC7.html)
CS165957B2 (cg-RX-API-DMAC7.html)
JPS4967911A (cg-RX-API-DMAC7.html)
JPS4966695A (cg-RX-API-DMAC7.html)
FR2199918A5 (cg-RX-API-DMAC7.html)
JPS4881260A (cg-RX-API-DMAC7.html)
JPS48104811U (cg-RX-API-DMAC7.html)
JPS5323476Y2 (cg-RX-API-DMAC7.html)
JPS532628Y2 (cg-RX-API-DMAC7.html)
JPS5031810B1 (cg-RX-API-DMAC7.html)
JPS5230117B2 (cg-RX-API-DMAC7.html)
CS151840B1 (cg-RX-API-DMAC7.html)
CS154090B1 (cg-RX-API-DMAC7.html)
CS174317B1 (cg-RX-API-DMAC7.html)
JPS4891234U (cg-RX-API-DMAC7.html)
CS170922B1 (cg-RX-API-DMAC7.html)
JPS48107108U (cg-RX-API-DMAC7.html)
CH561632A5 (cg-RX-API-DMAC7.html)
DD100110A1 (cg-RX-API-DMAC7.html)
CH559647A5 (cg-RX-API-DMAC7.html)
CH563042A5 (cg-RX-API-DMAC7.html)